These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 25489667

  • 1. Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.
    Damico R, Kolb TM, Valera L, Wang L, Housten T, Tedford RJ, Kass DA, Rafaels N, Gao L, Barnes KC, Benza RL, Rand JL, Hamid R, Loyd JE, Robbins IM, Hemnes AR, Chung WK, Austin ED, Drummond MB, Mathai SC, Hassoun PM.
    Am J Respir Crit Care Med; 2015 Jan 15; 191(2):208-18. PubMed ID: 25489667
    [Abstract] [Full Text] [Related]

  • 2. Collagen 18A1/Endostatin Expression in the Progression of Right Ventricular Remodeling and Dysfunction in Pulmonary Arterial Hypertension.
    Ambade AS, Naranjo M, Tuhy T, Yu R, Marimoutou M, Everett AD, Shimoda LA, Zimmerman SL, Cubero Salazar IM, Simpson CE, Tedford RJ, Hsu S, Hassoun PM, Damico RL.
    Am J Respir Cell Mol Biol; 2024 Sep 15; 71(3):343-355. PubMed ID: 38861354
    [Abstract] [Full Text] [Related]

  • 3. Functional Impact of Human Genetic Variants of COL18A1/Endostatin on Pulmonary Endothelium.
    Goyanes AM, Moldobaeva A, Marimoutou M, Varela LC, Wang L, Johnston LF, Aladdin MM, Peloquin GL, Kim BS, Damarla M, Suresh K, Sato T, Kolb TM, Hassoun PM, Damico RL.
    Am J Respir Cell Mol Biol; 2020 Apr 15; 62(4):524-534. PubMed ID: 31922883
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
    Ogihara Y, Yamada N, Dohi K, Matsuda A, Tsuji A, Ota S, Ishikura K, Nakamura M, Ito M.
    J Cardiol; 2014 Feb 15; 63(2):149-53. PubMed ID: 24012334
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension.
    Gao L, Skinner J, Nath T, Lin Q, Griffiths M, Damico RL, Pauciulo MW, Nichols WC, Hassoun PM, Everett AD, Johns RA.
    Respir Res; 2024 Jun 06; 25(1):235. PubMed ID: 38844967
    [Abstract] [Full Text] [Related]

  • 9. Soluble TWEAK predicts hemodynamic impairment and functional capacity in patients with pulmonary arterial hypertension.
    Filusch A, Zelniker T, Baumgärtner C, Eschricht S, Frey N, Katus HA, Chorianopoulos E.
    Clin Res Cardiol; 2011 Oct 06; 100(10):879-85. PubMed ID: 21479966
    [Abstract] [Full Text] [Related]

  • 10. Tricuspid regurgitation duration correlates with cardiovascular magnetic resonance-derived right ventricular ejection fraction and predict prognosis in patients with pulmonary arterial hypertension.
    Cho IJ, Oh J, Chang HJ, Park J, Kang KW, Kim YJ, Choi BW, Shin S, Shim CY, Hong GR, Ha JW, Chung N.
    Eur Heart J Cardiovasc Imaging; 2014 Jan 06; 15(1):18-23. PubMed ID: 23704751
    [Abstract] [Full Text] [Related]

  • 11. Serum albumin concentration as an independent prognostic indicator in patients with pulmonary arterial hypertension.
    Snipelisky D, Jentzer J, Batal O, Dardari Z, Mathier M.
    Clin Cardiol; 2018 Jun 06; 41(6):782-787. PubMed ID: 29604093
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension.
    Heresi GA, Tang WH, Aytekin M, Hammel J, Hazen SL, Dweik RA.
    Eur Respir J; 2012 Apr 06; 39(4):939-44. PubMed ID: 21885398
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension.
    Fine NM, Chen L, Bastiansen PM, Frantz RP, Pellikka PA, Oh JK, Kane GC.
    Circ Cardiovasc Imaging; 2013 Sep 06; 6(5):711-21. PubMed ID: 23811750
    [Abstract] [Full Text] [Related]

  • 16. Impaired left ventricular mechanics in pulmonary arterial hypertension: identification of a cohort at high risk.
    Hardegree EL, Sachdev A, Fenstad ER, Villarraga HR, Frantz RP, McGoon MD, Oh JK, Ammash NM, Connolly HM, Eidem BW, Pellikka PA, Kane GC.
    Circ Heart Fail; 2013 Jul 06; 6(4):748-55. PubMed ID: 23709658
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension.
    So PP, Davies RA, Chandy G, Stewart D, Beanlands RS, Haddad H, Pugliese C, Mielniczuk LM.
    Am J Cardiol; 2012 May 15; 109(10):1504-9. PubMed ID: 22385756
    [Abstract] [Full Text] [Related]

  • 18. C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value.
    Scognamiglio G, Kempny A, Price LC, Alonso-Gonzalez R, Marino P, Swan L, D' Alto M, Hooper J, Gatzoulis MA, Dimopoulos K, Wort SJ.
    Heart; 2014 Sep 15; 100(17):1335-41. PubMed ID: 24790070
    [Abstract] [Full Text] [Related]

  • 19. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.
    van de Veerdonk MC, Kind T, Marcus JT, Mauritz GJ, Heymans MW, Bogaard HJ, Boonstra A, Marques KM, Westerhof N, Vonk-Noordegraaf A.
    J Am Coll Cardiol; 2011 Dec 06; 58(24):2511-9. PubMed ID: 22133851
    [Abstract] [Full Text] [Related]

  • 20. Detection of high-sensitivity troponin in outpatients with stable pulmonary hypertension identifies a subgroup at higher risk of adverse outcomes.
    Roy AK, McCullagh BN, Segurado R, McGorrian C, Keane E, Keaney J, Fitzgibbon MN, Mahon NG, Murray PT, Gaine SP.
    J Card Fail; 2014 Jan 06; 20(1):31-7. PubMed ID: 24333348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.